Key takeaways

  • Indian women have a distinct lipid pattern, higher triglycerides, lower HDL, smaller LDL particles, and often raised Lp(a), so cardiovascular risk appears at lipid values that look acceptable in Western charts.
  • A simple fasting (or non-fasting) lipid panel costs about Rs 300 to 800. Lp(a) should be checked once in a lifetime to catch hidden genetic risk.
  • Statins are among the safest, best-studied medicines in modern medicine; most reported muscle aches are not actually caused by the drug, and the benefits clearly outweigh the risks for those at real cardiovascular risk.
  • Statins must be stopped before pregnancy and during breastfeeding; the only oral cholesterol drug considered safe then is a bile-acid sequestrant.
  • Menopause raises LDL by 10 to 25 percent as estrogen falls, so the menopausal transition is a key moment to recheck your lipids.
  • Roughly 1 in 250 Indians has familial hypercholesterolemia, a genetic cause of very high cholesterol and early heart attacks that is treatable but often missed.

What cholesterol is, and why Indian women are at particular risk

Cholesterol is a waxy fat your body genuinely needs, for cell walls, hormones (including estrogen and progesterone), vitamin D, and digestion. It travels in the blood wrapped in proteins called lipoproteins. The ones that matter most are LDL ("bad" cholesterol), which can deposit in artery walls and form plaque; HDL ("good" cholesterol), which clears cholesterol away; triglycerides, a storage fat that also damages arteries; and lipoprotein(a), or Lp(a), a largely genetic particle that strongly raises risk on its own.

Indian women tend to have a specific lipid profile, part of what doctors call the Asian Indian metabolic pattern: higher triglycerides, lower HDL, LDL that may be only mildly raised but made of smaller, denser, more harmful particles, and raised Lp(a) in 25 to 30 percent of people. Central or belly fat is common even at a "normal" weight, alongside insulin resistance and low-grade inflammation. The result is that artery disease can begin early, at numbers a Western chart would call fine.

Because of this, the 2024 Lipid Association of India guidelines and ICMR cut-offs are stricter than older criteria. Several everyday factors push the numbers in the wrong direction: lots of refined carbohydrate (white rice, refined wheat, sweets) raises triglycerides; heavy use of palm oil or excess ghee raises LDL; inactivity lowers HDL; and tobacco lowers HDL while oxidising LDL.

Conditions common in women add further risk. Undertreated type 2 diabetes and PCOS-related insulin resistance worsen the lipid picture, an underactive Hypothyroidism in Indian Women: Diagnosis, Treatment & Pregnancy directly raises cholesterol, menopause raises LDL, and familial hypercholesterolemia (about 1 in 250 Indians) drives very high levels from birth.

The lipid panel: what to test and how to read it

A standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides. Non-fasting panels are now considered acceptable for most people and give similar information, so you no longer always need an empty stomach. The test costs roughly Rs 300 to 800 at most Indian labs and is included in many health packages.

A few add-on tests help in selected cases. Lp(a) is worth checking once in your life, since the value is stable and identifies hidden genetic risk (about Rs 600 to 1,500). Apolipoprotein B (ApoB) counts harmful particles and can be more accurate than LDL when triglycerides are high (Rs 500 to 1,200). High-sensitivity CRP, a marker of inflammation, can refine risk (Rs 300 to 800).

Indian targets (2024 Lipid Association of India and ICMR): LDL under 100 mg/dL is optimal for most adults, under 70 mg/dL for moderate-risk people (such as those with diabetes, hypertension, or a strong family history), and under 55 mg/dL for high-risk people (those with established heart disease). Non-HDL cholesterol targets sit 30 mg/dL above the LDL target. Triglycerides should be under 150 mg/dL; above 500 carries a risk of pancreatitis. HDL under 50 mg/dL is low for women, while above 60 is protective. For Lp(a), under 30 mg/dL is desirable and over 50 marks high risk.

When to test: from age 20 every five years, yearly from age 40 or if you have risk factors, when planning pregnancy, around menopause, and if you have PCOS, a history of gestational diabetes, thyroid disease, or a first-degree relative who had a heart attack early (before 55 in men or 65 in women). The government's NPCDCS programme offers free lipid screening at participating primary and community health centres.

Lifestyle first: food, movement, and weight

Diet is the foundation of cholesterol care, and it still helps even if you are on a statin. A Mediterranean-style pattern adapts well to Indian kitchens: plenty of vegetables and fruit; whole grains such as jowar, bajra, ragi, brown rice, dalia, and whole wheat; legumes like dal, rajma, chana, and sprouts; a daily handful of nuts and seeds (10 to 15 almonds, a few walnuts, a teaspoon or two of flaxseed); oily fish twice a week if you eat non-vegetarian; mustard or olive oil as the main cooking oil; and low-fat dairy in moderation.

Limit deep-fried foods (samosa, pakora, puri), large amounts of ghee or tropical oils (palm and coconut), full-fat dairy in excess, red and processed meats, sugary drinks, packaged snacks, and refined carbohydrates. Eliminate trans fats entirely, found in vanaspati, hydrogenated margarines, and some commercial baked and fried goods.

Some foods lower cholesterol with real evidence behind them: soluble fibre (oats, barley, beans, lentils, citrus, and psyllium husk or isabgol, 5 to 10 g daily) can drop LDL by 5 to 10 percent; plant sterols around 2 g a day add a similar effect; nuts trim LDL a few percent; and omega-3 from fish or supplements lowers triglycerides at higher doses.

Movement matters as much as the menu. Aim for about 150 minutes a week of brisk activity such as walking, cycling, swimming, or dancing, which raises HDL and lowers triglycerides, plus two to three sessions of strength training that improve insulin sensitivity. Losing 5 to 10 percent of body weight, when relevant, noticeably improves all your numbers; if weight is a struggle, see our guidance on weight loss with PCOS. Finally, quitting tobacco raises HDL within months and is one of the single most powerful things you can do for your heart.

Statins: when, which, and how much

Statins lower the liver's cholesterol production and are the most effective, best-studied lipid medicines, with strong evidence that they reduce heart attacks, strokes, and deaths. In India the workhorses are atorvastatin and rosuvastatin, both taken once daily and widely available as inexpensive generics (typically Rs 100 to 500 a month). Simvastatin, pravastatin, and pitavastatin are also used.

Statins come in intensities. Moderate-intensity doses (for example atorvastatin 10 to 20 mg or rosuvastatin 5 to 10 mg) lower LDL by 30 to 50 percent; high-intensity doses (atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg) lower it by more than 50 percent. Your doctor chooses based on your starting LDL, your target, and your overall risk.

Statins are recommended for: anyone with established cardiovascular disease; an LDL of 190 mg/dL or higher; diabetes between ages 40 and 75 with LDL above 70; or an estimated 10-year cardiovascular risk above 7.5 percent. Several factors specific to women lower the threshold to start, including a family history of early heart disease, autoimmune conditions like Lupus (SLE) in Indian Women: Diagnosis, Treatment, Pregnancy, a past Preeclampsia in Pregnancy: Diagnosis and Care in India, PCOS, early menopause, chronic kidney disease, or raised Lp(a). A coronary calcium score can help refine borderline decisions.

About side effects: muscle aches are reported by 10 to 20 percent of users, but trials show similar rates on placebo, so most are not truly caused by the drug. Serious harm (rhabdomyolysis, major liver injury) is very rare, under 1 in 10,000, and reversible if the drug is stopped. There is a small rise in diabetes risk at high doses that is outweighed by the benefit. The key message: if you get symptoms, work with your doctor to switch statins, lower the dose, or try alternate-day dosing rather than simply stopping. Lipids are usually rechecked 6 to 8 weeks after starting.

Beyond statins: ezetimibe, PCSK9 inhibitors and others

Ezetimibe blocks cholesterol absorption in the gut and lowers LDL by a further 15 to 20 percent when added to a statin. It is well tolerated, inexpensive (Rs 200 to 500 a month), and is the usual first add-on, available alone or combined with atorvastatin or rosuvastatin in a single tablet.

PCSK9 inhibitors (evolocumab, alirocumab) are injections given every two to four weeks that cut LDL by a further 50 to 60 percent. They are reserved for people with established heart disease or familial hypercholesterolemia who are not at goal on maximal statin plus ezetimibe, or for severe statin intolerance. Cost is high, around Rs 12,000 to 25,000 a month, and they are rarely covered by insurance, but they are available at major centres.

Bile-acid sequestrants (such as cholestyramine and colesevelam) lower LDL by 15 to 25 percent and are older drugs with side effects like constipation and drug interactions. Their special role: they are the only oral cholesterol medicine considered safe in pregnancy and breastfeeding, because they are not absorbed into the body.

Fibrates (mainly fenofibrate) chiefly lower triglycerides and are used when triglycerides are very high (above 500) to prevent pancreatitis. Newer options include inclisiran, a twice-yearly injection, and bempedoic acid for people who cannot tolerate statins; both have limited availability in India.

Pregnancy, breastfeeding and cholesterol

Statins are not used in pregnancy or breastfeeding, because cholesterol is essential for a baby's development and statins cross the placenta. If you take a statin and become pregnant or are planning to, stop it and tell your doctor. For most women the risk of a year or two off treatment is acceptable, since the underlying disease does not advance dramatically in that time.

Most other lipid medicines, PCSK9 inhibitors, ezetimibe, fibrates, are also avoided in pregnancy. The only oral cholesterol medicine considered safe is a bile-acid sequestrant, generally kept for women with very high LDL (severe familial hypercholesterolemia or prior heart events) who still need active treatment.

Pregnancy itself raises cholesterol a lot, total cholesterol can climb 25 to 50 percent and triglycerides far more. This is normal physiology, so routine lipid testing in pregnancy is usually not helpful, and levels return to baseline by 6 to 12 weeks after delivery. Restart your statin once breastfeeding ends.

If you have high cardiovascular risk, ask for pre-conception planning: optimise blood pressure, glucose, and weight, take folic acid, and switch medication where needed. Both gestational diabetes and pregnancy-related high blood pressure flag higher long-term heart risk, so postpartum follow-up of these factors really matters.

Menopause: the lipid storm

Estrogen protects your lipid profile, lowering LDL and raising HDL. As estrogen falls at menopause, that protection lifts: LDL typically rises 10 to 25 percent, HDL drops a little, and triglycerides may climb. This is a major reason women's heart-disease rates catch up to men's within 10 to 15 years of menopause.

Perimenopause and early menopause are therefore prime times to recheck your lipids, ideally with a yearly panel. Many women with previously normal numbers develop high cholesterol here, and even those already on a statin may need a higher dose or an add-on to stay at target.

Hormone replacement therapy (HRT) modestly improves lipids, but it is not a substitute for a statin when one is needed, because it does not reduce heart events the same way. Transdermal estrogen (patch or gel) is generally preferred for women with cardiovascular risk, and HRT can be used alongside a statin. See our guide to HRT options and costs in India.

Beyond cholesterol, postmenopausal women benefit from broad heart protection: blood-pressure control (see high blood pressure in women), diabetes care, weight and stress management, and treating obstructive sleep apnoea, which becomes more common after menopause. Gentle, structured movement and regular exercise also support mood, sleep, and metabolic health during the transition.

Familial hypercholesterolemia: the hidden Indian epidemic

Familial hypercholesterolemia (FH) is an inherited condition that causes very high LDL from birth and a sharply raised risk of early heart disease. The common (heterozygous) form affects roughly 1 in 250 Indians, far more than most people realise, while the rare severe form can cause heart problems even in childhood. Indian cardiology bodies have repeatedly flagged how often FH goes unrecognised.

Suspect FH if LDL is above 190 mg/dL in an adult (or above 160 in a child) with no other cause; if there are cholesterol deposits in tendons (tendon xanthomas), yellow patches around the eyes (xanthelasma), or a whitish ring around the cornea before age 45; or if close relatives had heart attacks early.

Diagnosis uses clinical scoring (such as the Dutch Lipid Network or Simon Broome criteria), sometimes with genetic testing. Crucially, because first-degree relatives have a 50 percent chance of also having FH, cascade screening of the family is essential. Many premature heart attacks in Indian families trace back to undiagnosed FH that could have been treated decades earlier.

Treatment is aggressive and effective: high-intensity statin (often from early adulthood, sometimes from age 8 to 10 in children), an LDL target below 70 mg/dL, ezetimibe added as needed, and a PCSK9 inhibitor when those are not enough. Specialist lipid clinics at centres such as AIIMS Delhi, KEM Mumbai, and CMC Vellore have particular expertise.

Putting it together: your overall heart-risk picture

Cholesterol is one part of your overall cardiovascular risk, not the whole story. Doctors estimate your 10-year risk using equations that combine age, sex, smoking, diabetes, blood pressure, and cholesterol. A single number on your report matters less than that bigger picture.

Several factors specific to women raise the stakes: a family history of early heart disease, autoimmune conditions such as lupus or rheumatoid arthritis, a past pre-eclampsia (which roughly doubles lifetime risk), gestational diabetes, PCOS, early menopause, chronic kidney disease, migraine with aura, and raised Lp(a). These should all be on the table when you and your doctor decide on treatment.

In borderline cases, extra tests can sharpen the decision. A coronary calcium score of zero suggests low risk and may let you defer a statin, while a high score points to real atherosclerosis and a reason to treat. Carotid ultrasound, ApoB, and Lp(a) testing can add useful detail.

A complete heart-protection bundle for Indian women combines the right statin, blood-pressure and diabetes control, a heart-friendly diet, regular exercise, weight management, good sleep, tobacco cessation, and attention to mental health. With consistent, well-chosen treatment, a 50 to 70 percent reduction in risk is realistic. Knowing the warning signs of stroke and recognising a cardiac emergency in women completes the picture.

Costs, insurance and specialist access in India

Diagnostic costs (2026 estimates): a lipid panel is about Rs 300 to 800; Lp(a) Rs 600 to 1,500; ApoB Rs 500 to 1,200; hs-CRP Rs 300 to 800; a thyroid panel to rule out a secondary cause Rs 400 to 1,000; and a combined cardiovascular screening package Rs 1,500 to 4,000. A coronary calcium score CT runs Rs 6,000 to 15,000 and a carotid Doppler Rs 1,000 to 3,000.

Monthly treatment costs are modest for most people: atorvastatin or rosuvastatin Rs 100 to 500; ezetimibe Rs 200 to 500; a fixed-dose statin-ezetimibe tablet Rs 200 to 600; fenofibrate Rs 200 to 500. The expensive end is reserved for select patients, PCSK9 inhibitors Rs 12,000 to 25,000 a month and inclisiran Rs 25,000 to 40,000 per six-monthly injection. Most people on standard therapy spend Rs 100 to 600 a month, and Jan Aushadhi pharmacies cut this further.

Several schemes help with costs: Ayushman Bharat PMJAY covers cardiovascular workup and treatment at empanelled hospitals; CGHS, ECHS, and ESI cover their beneficiaries; state schemes (such as Tamil Nadu CMCHIS, Telangana and AP Aarogyasri, Kerala KASP, Karnataka Arogya Karnataka) add coverage; and NPCDCS offers free lipid screening at participating PHCs and CHCs.

Most cholesterol care can be handled by your family doctor or a general physician. Ask for a referral to a cardiologist or endocrinologist if your LDL is 190 or higher, FH is suspected, you cannot tolerate statins, your lipids stay high despite treatment, or you have established heart disease. The Lipid Association of India (lipidindia.com) maintains a directory of specialists.

When to see a doctor

High cholesterol itself is silent, so testing, not symptoms, is how it is found. Book a lipid panel if you have not been screened and are over 20, are approaching menopause, are planning a pregnancy, or have diabetes, PCOS, thyroid disease, high blood pressure, or a family history of early heart attack or stroke.

See a doctor promptly if your LDL is 190 mg/dL or higher, if your triglycerides are above 500 (a pancreatitis risk), if you notice cholesterol deposits in your tendons, yellow patches near your eyes, or a pale ring around the cornea before middle age, or if close relatives had heart attacks young, all of which can point to familial hypercholesterolemia.

Do not stop a statin on your own if you feel muscle aches; speak to your doctor about switching, lowering the dose, or testing, because stopping after a heart event sharply raises the risk of another.

Cholesterol myths in India, corrected

Myth: Statins are dangerous, so it is safer to avoid them

  • Fact: Statins are among the most studied and safest medicines in modern medicine; for people at real cardiovascular risk the benefit clearly outweighs the risk.
  • Fact: Muscle aches affect 10 to 20 percent of users, but trials show similar rates on placebo, so most are not actually caused by the drug.
  • Fact: Serious harm (rhabdomyolysis, major liver injury) is very rare, under 1 in 10,000, and reversible on stopping.
  • Fact: Swapping a statin for herbal alternatives or lifestyle alone has led to many preventable heart attacks in India.
  • Fact: If you have side effects, work with your doctor to rotate statins, lower the dose, or try alternatives, do not simply stop.

Myth: Ghee and coconut oil are traditional, so they do not raise cholesterol

  • Fact: Both are mostly saturated fat and do raise LDL when used in large amounts.
  • Fact: A little ghee (1 to 2 tsp a day) is fine for most people; large amounts (5+ tsp a day) clearly worsen lipids.
  • Fact: Palm and coconut oil raise LDL despite their healthy reputation.
  • Fact: Better cooking oils for the heart include mustard, olive, sesame, sunflower, and rice-bran oil, used in moderation.
  • Fact: "Traditional" does not automatically mean heart-healthy; diets evolved when people were far more physically active.

Myth: My numbers are only slightly high, so I do not need treatment

  • Fact: Indian women develop heart disease at lower lipid values than Western charts assume.
  • Fact: The decision to treat is based on overall risk, not the LDL number alone, someone with diabetes, hypertension, and family history may benefit even with a near-normal LDL.
  • Fact: Raised Lp(a) affects about 1 in 4 Indians and is a strong, often-overlooked risk factor, get it checked once.
  • Fact: Women-specific factors (past pre-eclampsia, PCOS, autoimmune disease, early menopause) lower the threshold to treat.
  • Fact: A coronary calcium score can help decide in borderline cases.

Myth: After a heart attack my cholesterol "looks fine," so I can skip the statin

  • Fact: After established heart disease, a statin is indicated regardless of the starting number, the benefit is fewer future events, not just a lower lipid reading.
  • Fact: Post-event LDL targets are aggressive (below 70, ideally below 55), so even normal-looking numbers may not be at target.
  • Fact: If LDL stays above target on a statin, add ezetimibe, and consider a PCSK9 inhibitor if still high.
  • Fact: Stopping a statin after a heart attack sharply raises the risk of another, long-term adherence is essential.
  • Fact: Generic statins are cheap and widely available; cost is rarely a genuine barrier, and Jan Aushadhi pharmacies discount further.

Frequently asked questions

Can I lower my cholesterol with diet alone, without medication?

If your cholesterol is only mildly raised and your overall heart risk is low, diet, exercise, weight loss, and quitting tobacco can be enough, and your doctor may give you a few months to try this first. But if you have high overall risk (diabetes, established heart disease, very high LDL, or familial hypercholesterolemia), lifestyle helps but is not a substitute for a statin. The decision depends on your whole risk picture, not the number alone.

Do I really need to fast before a cholesterol test?

Often not. Non-fasting lipid panels are now accepted for most people and give similar information. Your doctor may still ask you to fast if triglycerides are very high or specific calculations are needed, so follow the lab's instruction for your particular test.

Are statins safe to take long term?

Yes. Statins are designed for long-term use and are among the best-studied medicines we have. Serious side effects are rare and reversible, and the protection against heart attack and stroke builds over years. Your doctor will recheck your lipids and liver enzymes periodically, but most people take them safely for decades.

What should I do about my statin if I want to get pregnant?

Stop the statin before trying to conceive and tell your doctor, statins are not used in pregnancy or breastfeeding. For most women the underlying disease does not worsen much over a year or two off treatment. If your risk is very high, your doctor may switch you to a bile-acid sequestrant, the only oral cholesterol drug considered safe in pregnancy. Restart the statin once breastfeeding ends.

Why did my cholesterol rise after menopause even though my diet has not changed?

Estrogen helps keep LDL low and HDL high. As estrogen falls at menopause, LDL commonly rises by 10 to 25 percent regardless of diet. This is why the menopausal transition is an important time to recheck your lipids and, if needed, start or adjust treatment.

What is Lp(a), and why should I test it once?

Lipoprotein(a), or Lp(a), is a largely genetic cholesterol particle that independently raises heart-disease risk and is high in about 1 in 4 Indians. Its value stays roughly stable through life, so a single test identifies hidden risk that a standard panel can miss. A high result is a reason for stricter control of all your other risk factors.

Sources